The anti-obesogenic effect of TZT may reduce Covid-19 severity by ameliorating body weight and adiposity
Existing therapeutic options fail to halt neurodegeneration by modulating metabolic dysfunction, leaving the neuroprotective clinical needs largely unmet
13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura
The useful comparison puts evidence, expected results, side effects, dosing or delivery, cost, access, and provider oversight in the same view so the reader can see which tradeoff actually changes the choice
Chickenpox causes shingles